FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179969410> ?p ?o ?g. }

• W3179969410 endingPage "1819" @default.
• W3179969410 startingPage "1809" @default.
• W3179969410 abstract "Abstract Dual bromodomain BET inhibitors that bind with similar affinities to the first and second bromodomains across BRD2, BRD3, BRD4, and BRDT have displayed modest activity as monotherapy in clinical trials. Thrombocytopenia, closely followed by symptoms characteristic of gastrointestinal toxicity, have presented as dose-limiting adverse events that may have prevented escalation to higher dose levels required for more robust efficacy. ABBV-744 is a highly selective inhibitor for the second bromodomain of the four BET family proteins. In contrast to the broad antiproliferative activities observed with dual bromodomain BET inhibitors, ABBV-744 displayed significant antiproliferative activities largely although not exclusively in cancer cell lines derived from acute myeloid leukemia and androgen receptor positive prostate cancer. Studies in acute myeloid leukemia xenograft models demonstrated antitumor efficacy for ABBV-744 that was comparable with the pan-BET inhibitor ABBV-075 but with an improved therapeutic index. Enhanced antitumor efficacy was also observed with the combination of ABBV-744 and the BCL-2 inhibitor, venetoclax compared with monotherapies of either agent alone. These results collectively support the clinical evaluation of ABBV-744 in AML (Clinical Trials.gov identifier: NCT03360006)." @default.
• W3179969410 created "2021-07-19" @default.
• W3179969410 creator A5004428348 @default.
• W3179969410 creator A5006968052 @default.
• W3179969410 creator A5011099905 @default.
• W3179969410 creator A5021063321 @default.
• W3179969410 creator A5022647201 @default.
• W3179969410 creator A5026984704 @default.
• W3179969410 creator A5029810586 @default.
• W3179969410 creator A5030590415 @default.
• W3179969410 creator A5034213336 @default.
• W3179969410 creator A5034559027 @default.
• W3179969410 creator A5036343829 @default.
• W3179969410 creator A5036792126 @default.
• W3179969410 creator A5037648687 @default.
• W3179969410 creator A5038565152 @default.
• W3179969410 creator A5040413688 @default.
• W3179969410 creator A5044757881 @default.
• W3179969410 creator A5044796135 @default.
• W3179969410 creator A5047351832 @default.
• W3179969410 creator A5056984007 @default.
• W3179969410 creator A5060246593 @default.
• W3179969410 creator A5066723560 @default.
• W3179969410 creator A5067657823 @default.
• W3179969410 creator A5070218289 @default.
• W3179969410 creator A5070247681 @default.
• W3179969410 creator A5071658726 @default.
• W3179969410 creator A5074957787 @default.
• W3179969410 creator A5076720827 @default.
• W3179969410 creator A5078103055 @default.
• W3179969410 creator A5079588934 @default.
• W3179969410 creator A5087031558 @default.
• W3179969410 creator A5089336759 @default.
• W3179969410 date "2021-07-12" @default.
• W3179969410 modified "2023-10-05" @default.
• W3179969410 title "Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia" @default.
• W3179969410 cites W1966227037 @default.
• W3179969410 cites W1971407164 @default.
• W3179969410 cites W1971578941 @default.
• W3179969410 cites W1973912384 @default.
• W3179969410 cites W1976033223 @default.
• W3179969410 cites W2002395443 @default.
• W3179969410 cites W2024469844 @default.
• W3179969410 cites W2048660424 @default.
• W3179969410 cites W2060484997 @default.
• W3179969410 cites W2070033262 @default.
• W3179969410 cites W2091368230 @default.
• W3179969410 cites W2102619694 @default.
• W3179969410 cites W2120572492 @default.
• W3179969410 cites W2129129812 @default.
• W3179969410 cites W2131387803 @default.
• W3179969410 cites W2161371146 @default.
• W3179969410 cites W2171808845 @default.
• W3179969410 cites W2216772862 @default.
• W3179969410 cites W2298793032 @default.
• W3179969410 cites W2300442403 @default.
• W3179969410 cites W2376907976 @default.
• W3179969410 cites W2491205940 @default.
• W3179969410 cites W2606852909 @default.
• W3179969410 cites W2889751512 @default.
• W3179969410 cites W2896584957 @default.
• W3179969410 cites W3001038414 @default.
• W3179969410 cites W3011089475 @default.
• W3179969410 doi "https://doi.org/10.1158/1535-7163.mct-21-0029" @default.
• W3179969410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34253595" @default.
• W3179969410 hasPublicationYear "2021" @default.
• W3179969410 type Work @default.
• W3179969410 sameAs 3179969410 @default.
• W3179969410 citedByCount "11" @default.
• W3179969410 countsByYear W31799694102022 @default.
• W3179969410 countsByYear W31799694102023 @default.
• W3179969410 crossrefType "journal-article" @default.
• W3179969410 hasAuthorship W3179969410A5004428348 @default.
• W3179969410 hasAuthorship W3179969410A5006968052 @default.
• W3179969410 hasAuthorship W3179969410A5011099905 @default.
• W3179969410 hasAuthorship W3179969410A5021063321 @default.
• W3179969410 hasAuthorship W3179969410A5022647201 @default.
• W3179969410 hasAuthorship W3179969410A5026984704 @default.
• W3179969410 hasAuthorship W3179969410A5029810586 @default.
• W3179969410 hasAuthorship W3179969410A5030590415 @default.
• W3179969410 hasAuthorship W3179969410A5034213336 @default.
• W3179969410 hasAuthorship W3179969410A5034559027 @default.
• W3179969410 hasAuthorship W3179969410A5036343829 @default.
• W3179969410 hasAuthorship W3179969410A5036792126 @default.
• W3179969410 hasAuthorship W3179969410A5037648687 @default.
• W3179969410 hasAuthorship W3179969410A5038565152 @default.
• W3179969410 hasAuthorship W3179969410A5040413688 @default.
• W3179969410 hasAuthorship W3179969410A5044757881 @default.
• W3179969410 hasAuthorship W3179969410A5044796135 @default.
• W3179969410 hasAuthorship W3179969410A5047351832 @default.
• W3179969410 hasAuthorship W3179969410A5056984007 @default.
• W3179969410 hasAuthorship W3179969410A5060246593 @default.
• W3179969410 hasAuthorship W3179969410A5066723560 @default.
• W3179969410 hasAuthorship W3179969410A5067657823 @default.
• W3179969410 hasAuthorship W3179969410A5070218289 @default.
• W3179969410 hasAuthorship W3179969410A5070247681 @default.
• W3179969410 hasAuthorship W3179969410A5071658726 @default.
• W3179969410 hasAuthorship W3179969410A5074957787 @default.

• next